Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 4/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | DHODH | Q02127 | 6/20 | 0.46 |
| ▸ | TACR3 | P29371 | 6/20 | 0.45 |
| ▸ | TACR2 | P21452 | 3/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4906728 | 0.84 | PDE10A (0.51) | PDE10ACYP2D6CYP2C19TSHRLMNA | |
| SCHEMBL6363272 | 0.82 | TACR3 (0.62) | TACR3TACR2OPRM1 | |
| SCHEMBL6853585 | 0.81 | POLB (0.48) | PDE10ACYP2D6CYP2C19TSHRLMNA | |
| SCHEMBL4665929 | 0.79 | TACR3 (0.64) | PDE10ACYP2D6CYP2C19TSHRLMNA | |
| SCHEMBL6853322 | 0.78 | TACR3 (0.51) | PDE10ATSHRLMNAPOLBTACR3 | |
| SCHEMBL8267077 | 0.77 | PDE10A (0.59) | PDE10ACYP2D6CYP2C19TSHRLMNA | |
| SCHEMBL6199463 | 0.75 | TACR3 (0.49) | TACR3TACR2OPRM1 | |
| SCHEMBL7691041 | 0.75 | PDE10A (0.57) | PDE10ACYP2D6CYP2C19TSHRLMNA | |
| SCHEMBL8268023 | 0.74 | PDE10A (0.56) | PDE10ACYP2D6CYP2C19TSHRLMNA | |
| SCHEMBL5437415 | 0.72 | PDE10A (0.57) | PDE10ACYP2D6CYP2C19TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1377567-B1 | QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS | GLAXOSMITHKLINE SPA (IT) | 2005-12-21 | — | — | EP | claimed |
| EP-1377567-A1 | QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS | GlaxoSmithKline S.p.A. (IT) | 2004-01-07 | — | — | EP | disclosed |
| WO-2002083663-A1 | QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS | GLAXOSMITHKLINE S.P.A. (IT) | 2002-10-24 | — | — | WO | disclosed |